Inhibitory Effect of Shenci Capsule in Combination with DDP on Angiogenesis in Mice with Lewis Lung Cancer

XU Li-qun,ZHANG Rong-hua,XUE Xing-yang,WU Xiao-dong,FU Shu-ping,CAI Yu,LIANG Kun,CHEN Rui-shen
DOI: https://doi.org/10.3969/j.issn.1000-4718.2010.12.012
2010-01-01
Abstract:AIM:To investigate the inhibitory effect of Shenci capsule,a Chinese medicine,in combination with cisplatin(DDP) on the tumor growth and angiogenesis in mouse Lewis lung cancer.METHODS: Forty mice with Lewis lung cancer were randomly divided into 4 groups: Shenci capsule group,Shenci capsule in combination with DDP group,DDP group and control group.Shenci capsule,Shenci capsule in combination with DDP,DDP and sodium chloride wene given,respectively.After 21 days,the weight of subcutaneous tumors was measured,and the tumor inhibition rate was calculated.The microvessel density(MVD) and the protein level of vascular endothelial growth factor(VEGF) were detected by immunohistochemical(IHC) staining.The mRNA expression levels of kinase insert domain-containing receptor(KDR) and the receptor of VEGF were detected by FQ-PCR.RESULTS: The tumor growth inhibitory rate in Shenci capsule in combination with DDP group(63.99%) was higher than that in Shenci capsule group,DDP group and control group(P0.01).The tumor MVD,VEGF protein and KDR mRNA expression level in Shenci capsule in combination with DDP group were lower than those in the above three groups(P0.01).CONCLUSION: Shenci capsule in combination with DDP have addition or synergistic effects to inhibit the tumor growth and angiogenesis in mouse Lewis lung cancer.Down-regulation of VEGF and its receptor KDR may be one of the mechanisms that combined use of these two drugs for inhibiting angiogenesis.
What problem does this paper attempt to address?